Why Patients Are Losing Faith in Medicine — and What One New Study Is Proposing Instead

Trust in the American healthcare system has been on a downward trend for quite some time, and the pandemic made things worse. Back in April 2020, around 71.5% of Americans felt they could rely on doctors and hospitals. Fast forward to January 2024, and that number has plummeted to just 40.1%.

This decline isn’t merely a reaction to pandemic exhaustion. It reflects a deeper concern among patients—that medical choices are increasingly influenced by corporate and financial interests rather than the needs of individuals.

The Wellness Company was established with a different approach in mind, prioritizing patient care over profit. This guiding principle is at the heart of one of their key research projects: a pioneering study led by Dr. Peter McCullough and his team, examining the effectiveness of combining Ivermectin and Mebendazole in cancer treatment.

This innovative research has been peer-reviewed and published in Anticancer Research, a significant journal in the field of oncology.

Most Patients in New Analysis Reported a Clinical Benefit

A recently published observational analysis revealed that 84.4% of cancer patients treated off-label with a compounded mix of Ivermectin and Mebendazole reported clinical benefits. Since both drugs are affordable, easily accessible, and well-known, these results highlight a promising, low-cost avenue worth exploring further in cancer therapy.

The report, created by The Wellness Company’s Chief Medical Board in collaboration with the McCullough Foundation, monitored 197 cancer patients who received a U.S.-compounded formulation: 25 mg of Ivermectin combined with 250 mg of Mebendazole.

Among the 122 patients who reached the six-month follow-up:

• 84.4% reported clinical benefit (evidence of no disease, tumor reduction, or stable condition)
• 48.4% experienced notable positive outcomes (tumor reduction or no current signs of disease)
• 86.9% completed their initial prescription (most side effects reported were mild)

The reasoning behind this drug combination ties to their mechanisms of action. Both are FDA-approved and derive from Nobel Prize-winning research. Ivermectin is thought to disrupt the pathways that tumors utilize to grow and to initiate programmed cell death in cancer cells. Mebendazole operates differently by depriving abnormal cells of glucose. Together, they form a straightforward regimen in a single capsule, which patients largely adhered to.

Cancer is a prevalent diagnosis in the U.S., with about one in three Americans facing it during their lifetime. However, conventional treatments like chemotherapy and radiation come with considerable downsides: severe side effects, high costs, resistance to treatment, and widely varying outcomes.

These challenges motivated The Wellness Company’s researchers to seek alternatives. Ivermectin and Mebendazole have already exhibited anti-cancer properties in earlier studies, and they’ve been used safely for decades in other areas. What’s needed is rigorous clinical evidence demonstrating their combined effectiveness in actual cancer patients, which this analysis aims to help establish.

Dr. McCullough remarked, “This study uncovers an exciting new potential that could broaden the use of Ivermectin and Mebendazole in treating various cancers. We urgently require comprehensive scientific research on this category of medications and their effects on cancer care.”

How You Can Get Ivermectin + Mebendazole

The Wellness Company is unique in its ability to prescribe compounded Ivermectin and Mebendazole in high-dose tablets:

Ivermectin – Recognized for its scientific basis and Nobel Prize recognition, it effectively targets parasitic infections, offering reliable care for families.

Mebendazole – Valued by healthcare professionals, it efficiently attacks and eliminates intestinal parasites, ensuring health and safety with proven effectiveness.

Visit The Wellness Company today to order a 45-day or 90-day supply of this combined treatment for parasite cleansing. Just complete a brief medical intake form after your order to finish your prescription request. Available for U.S. residents only.

Testimonials about The Wellness Company’s Ivermectin + Mebendazole:

I was in stage 4 and terminal with metastatic breast cancer throughout my body. Last month, my PET scan showed no active cancer cells anywhere. Ivermectin and Mebendazole were game changers for me. – Judith M.

My daughter had uterine cancer and lung nodules that were confirmed as cancerous. After starting the Ivermectin/Mebendazole treatment two weeks ago, her recent PET scan showed very few nodules remaining, with the physician having to search for a sample. I’m incredibly grateful to this medical team for providing us with hope and healing! – Helen